Provision of Personalized Care Through the Use of Precision Medicine
Presentation
Overview
Overview
Description
The American Nurses Association (ANA) and the Institute of Medicine (IOM) have both identified the need to prepare nurses to take part in genomic health care services. According to the Food and Drug Administration, there are currently over 50 different oncology drugs that utilize pharmacogenomic information for guidance surrounding prescription. Therefore, it is imperative that oncology nurses and providers understand the role of precision medicine within oncology care to not only provide proper medications but ensure confidence in their ability to advocate and provide education for their patients as well.
Purpose
The purpose of this activity is to provide basic information surrounding the most commonly seen pharmacogenomic tests available within the oncology setting. Additionally, a goal of this activity is to provide knowledge on the implications of precision medicine for nursing practice, patient advocacy, and patient education.
